教育经历

• ▪2001.9-2006.6 本科 临床医学，中南大学湘雅医学院
• ▪2006.9-2009.6 硕士 肿瘤学，中南大学湘雅医学院
• ▪2016.9- 2019.6 博士 肿瘤学，南京医科大学
• ▪2019.9-2020.9 访问学者 放射肿瘤学，美国德州大学MD安德森肿瘤中心

学术贡献

• 以第一或通讯作者身份发表Oncogene, Cell Chemical Biology, Radiotherapy Oncology, Frontiers in immunology，Oral Oncology 等高水平SCI专业论文20余篇，主持国家自然科学基金及江苏省“333人才”优秀青年项目等多项基金。
• 参与编书：
• 参与编写人卫版教材《肿瘤放射肿瘤学》，参与编译《血液系统恶性肿瘤放射治疗》、《亨迪放射治疗物理学》(第4版)。
• 代表论著：
• 1、Alvan Amos，Ning Jiang, Dan Zong, Jiajia Gu, Jiawei Zhou, Li Yin, Xia He*, Yong Xu* and Lirong Wu* (吴俚蓉，通讯作者). Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition. BMC Cancer 2023 23:117. （英国BMC期刊，医学2区，SCI 4.3）
• 2、Binbin Chen, Ying Huang, Shuiqing He, Peng Yu, Lirong Wu*(吴俚蓉，通讯作者), Hao Peng*. N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis. Cell Chemical Biology 2023 30, 144–158. （Cell旗下重点子刊,生物学1区，SCI 9.04）
• 3、Lirong Wu（吴俚蓉，第一作者）, Xinxin Zhao, Suqing Tian, Kaixian Zhang, Chuang He, Yong Feng, Jiawei Zhou, Wenjie Guo, Zhe Ji, Xia He, Guanglie Chen and Junjie Wang. Efficacy and toxicity of Iodine-125 seed implantation for lymph node recurrence secondary to esophageal cancer after radiotherapy: a multicenter retrospective study. Radiation Oncology 2023, 18:18. （放射治疗学重点期刊,医学2区，SCI 4.31）
• 4、Xu T, Wu L （吴俚蓉，并列第一作者）, Gandhi S, Jing W, Nguyen QN, Chen A, Chang JY, Nurieva R, Sheshadri A, Altan M, Lee PP, Lin SH, Liao Z. Treatment Related Pulmonary Adverse Events Induced by Chemoradiation and Durvalumab Affect Survival in Locally Advanced Non-Small Cell Lung Cancer. Radiotherapy Oncology. 2022 Oct 6:S0167-8140 （欧洲放射肿瘤学会会刊，医学1区，SCI 8.4）
• 5、Binbin Chen, Wei Jiang, Ying Huang, Jian Zhang, Peng Yu, Lirong Wu (吴俚蓉，通讯作者), Hao Peng. N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma. Oncogene. 2022; 41, pages2239–2253. (Nature杂志社旗下重点子刊，医学1区，SCI 10)
• 6、Lirong Wu（吴俚蓉，第一作者）, Jun Zhu, Nils-Petter Rudqvist, James Welsh, Percy Lee, Zhongxing Liao, Ting Xu, Ming Jiang, Xiangzhi Zhu, Xuan Pan, Pansong Li, Zhipeng Zhou, Xia He, Rong Yin, Jifeng Feng. T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy for Stage I Non-Small-Cell Lung Cancer. Frontiers in immunology. 2021, Oct 18；12:719285. (国际免疫学会联合会的官方期刊，医学1区，SCI 8.8)
• 7、Lirong Wu（吴俚蓉，第一作者）， Wang J, Zhu D, Zhang S, Zhou X, Zhu J, He X: Circulating Epstein-Barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosis. Cancer Biomark. 2020, 27(3):365-375. 3 March 2020. （中科院分区3区，SCI 4.4）
• 8、 Huo Zhang, Xuan Zou, Lirong Wu (吴俚蓉，并列一作), Shiyu Zhang, Tongshan Wang, Ping Liu, Wei Zhu, Jun Zhu. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Cancer Medicine 2020, 9(3): 1230-1241. （中科院分区3区，SCI 4.7分）
• 9、Lirong Wu（吴俚蓉，第一作者），Xiuming Zhang, Xiaodong Xie, Yue Lu, Jianfeng Wu, Xia He*. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up. Oral Oncology. 2019; 98: 141-146. （中科院医学2区 SCI 5.3）
• 10、Lirong Wu（吴俚蓉，第一作者），Kexiao Zheng, Cheng Yan, Xuan Pan, Yatian Liu, Juying Liu, Feijiang Wang, Wenjie Guo, Xia He*, Jiong Li*, Ye Shen*. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma. BMC Cancer. 2019; 19:843. 2019-5-1 （英国BMC期刊，医学2区，SCI 3.15）
• 国际会议论文：
• 1 Li-Rong Wu（吴俚蓉，第一作者）, Huan-feng Zhu, Jianhua Xu, Xiu-hua Bian, Jian-feng Wu, Dan Song, Xue-song Jiang, Feng Li, Fei-jiang Wang, Sheng-fu Huang, Wen-jie Guo, Xia He. Effectiveness and toxicities of cetuximab in combination with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis. European Societyfor Medical Oncology (ESMO) 2017 Congress. Annals of Oncology. Madrid, Spain 8-12 September, 2017 (Publication Number: 1072P). 欧洲肿瘤年会
• 2 Li-Rong Wu（吴俚蓉，第一作者）, Xia He, Ye Shen. Genome-Wide Study of Salivary microRNAs As Potential Noninvasive Biomarkers for Detection of Nasopharyngeal Carcinoma. American Society for Radiation Oncology (ASTRO) 2019 Congress. Chicago, United States. 15-18 September, 2018 (Publication Number: 3555). 美国放射肿瘤年会
• 3 Li-Rong Wu（吴俚蓉，第一作者）, Zhang, Xiuming; Xie, Xiao-Dong; Lu, Yue; Wu, Jian-Feng; He Xia. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up. European Society for Medical Oncology (ESMO) Asia Congress 2019. Singapore. 22-24 November, 2019 (Publication Number: 294P). 欧洲肿瘤年会亚洲年会
• 4 Lirong Wu（吴俚蓉，第一作者），T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy for Stage I Non-Small-Cell Lung Cancer. American Society for Radiation Oncology (ASTRO) 2020 Congress. Chicago, United States. 25 October, 2020 (Publication Number: 2243). 美国放射肿瘤年会
• 5、Li Wang, Jiawei Zhou, Ting Qiu, Yinsu Zhu, Baozhou Sun, Guanyu Yang, Shengfu Huang, Xla He, Lirong Wu（吴俚蓉,通讯作者），Deep Transfer Learning and Dosiomics for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma (ASTRO) 2024 Congress. Washington DC, United States. 29 September, 2024 (Publication Number: 62672). 美国放射肿瘤年会
• 6、Junyi Liu, L. Wang, J. Zhou1, T. Qiu1, Y. Zhu, B. Sun, G. Yang, S. Huang, X. He, and Lirong Wu（吴俚蓉,通讯作者）. Compare the Predictive Performance of Deep Learning and Radiomics Models for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma. (ASTRO) 2024 Congress. Washington DC, United States. 29 September, 2024 (Publication Number: 64618). 美国放射肿瘤年会
• 7、Li Wang , Jiawei Zhou , Ting Qiu, Yinsu Zhu, Baozhou Sun, Guanyu Yang , Shengfu Huang, Lirong Wu（吴俚蓉,通讯作者）, Xia He. A MRI-based radiomics-clinical machine learning model for predicting radiationinduced temporal lobe injury. Helsinki，Finland，29 June，2024 欧洲神经病学年会

工作经历